Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson's disease

被引:19
作者
Sklerov, Miriam [1 ]
Shih, Chia-Hao [2 ]
Browner, Nina [1 ]
Palma, Jose-Alberto [3 ]
Styner, Martin [4 ]
Dayan, Eran [5 ,6 ]
机构
[1] Univ N Carolina, Dept Neurol, 170 Manning Dr,CB 7025, Chapel Hill, NC 27599 USA
[2] Univ Toledo, Dept Psychiat, Ruppert Hlth Ctr 0004,Mail Stop 1193, Toledo, OH 43614 USA
[3] NYU, Dysauton Ctr, Dept Neurol, Med Ctr, 530 First Ave,Suite 9Q, New York, NY 10016 USA
[4] Univ N Carolina, Dept Psychiat, 352 Med Sch Wing C, Chapel Hill, NC 27516 USA
[5] Univ N Carolina, Biomed Res Imaging Ctr, 130 Mason Farm Rd,CB 7513, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Dept Radiol, 130 Mason Farm Rd,CB 7513, Chapel Hill, NC 27599 USA
关键词
Activities of daily living; Autonomic symptoms; Depressive symptoms; Parkinson's disease; QUALITY-OF-LIFE; ORTHOSTATIC HYPOTENSION; PROGRESSION; DYSFUNCTION; SURVIVAL; IMPACT; SCALE;
D O I
10.1007/s10286-020-00672-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose The primary objective of this study was to examine the relationship of longitudinal changes in autonomic symptom burden and longitudinal changes in activities of daily living (ADLs); a secondary analysis examined the impact of depressive symptoms in this relationship. Methods Data were retrieved from the Parkinson's Progression Markers Initiative (PPMI), a dataset documenting the natural history of newly diagnosed Parkinson's disease (PD). The analysis focused on data from baseline, visit 6 (24 months after enrollment), and visit 12 (60 months after enrollment). The impact of longitudinal changes in autonomic symptom burden on longitudinal changes in ADLs function was examined. A secondary mediation analysis was performed to investigate whether longitudinal changes in depressive symptoms mediate the relationship between longitudinal changes in autonomic symptom burden and ADLs function. Results Changes in autonomic symptom burden, cognitive function, depressive symptoms, and motor function all correlated with ADLs. Only changes in ADLs and depression were found to be associated with changes in autonomic symptom burden. We found that longitudinal change in autonomic symptoms was a significant predictor of change in ADLs at 24 and 60 months after enrollment, with the cardiovascular subscore being a major driver of this association. Mediation analysis revealed that the association between autonomic symptoms and ADLs is partially mediated by depressive symptoms. Conclusions Longitudinal changes in autonomic symptoms impact ADLs function in patients with early signs of PD, both directly and indirectly through their impact on depressive symptoms. Future investigation into the influence of treatment of these symptoms on outcomes in PD is warranted.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 33 条
  • [21] Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies
    Pilotto, Andrea
    Romagnolo, Alberto
    Tuazon, Jasmine A.
    Vizcarra, Joaquin A.
    Marsili, Luca
    Zibetti, Maurizio
    Rosso, Michela
    Rodriguez-Porcel, Federico
    Borroni, Barbara
    Rizzetti, Maria Cristina
    Rossi, Carlo
    Vizcarra-Escobar, Darwin
    Molano, Jennifer R.
    Lopiano, Leonardo
    Ceravolo, Roberto
    Masellis, Mario
    Espay, Alberto J.
    Padovani, Alessandro
    Merola, Aristide
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (11) : 1257 - 1263
  • [22] The impact of depressive symptoms in early Parkinson disease
    Ravina, B.
    Camicioli, R.
    Como, P. G.
    Marsh, L.
    Jankovic, J.
    Weintraub, D.
    Elm, J.
    [J]. NEUROLOGY, 2007, 69 (04) : 342 - 347
  • [23] Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
    Remy, P
    Doder, M
    Lees, A
    Turjanski, N
    Brooks, D
    [J]. BRAIN, 2005, 128 : 1314 - 1322
  • [24] Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease
    Sagna, Atami
    Gallo, Joseph J.
    Pontone, Gregory M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2014, 20 (07) : 708 - 715
  • [25] Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease
    Sharabi, Yehonatan
    Goldstein, David S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 310 (1-2) : 123 - 128
  • [26] Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
    Simuni, Tanya
    Long, Jeffrey D.
    Caspell-Garcia, Chelsea
    Coffey, Christopher S.
    Lasch, Shirley
    Tanner, Caroline M.
    Jennings, Danna
    Kieburtz, Karl D.
    Marek, Kenneth
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (07): : 482 - 494
  • [27] Functional neuroimaging of the central autonomic network: recent developments and clinical implications
    Sklerov, Miriam
    Dayan, Eran
    Browner, Nina
    [J]. CLINICAL AUTONOMIC RESEARCH, 2019, 29 (06) : 555 - 566
  • [28] Determinants of health-related quality of life in Parkinson's disease: A systematic review
    Soh, Sze-Ee
    Morris, Meg E.
    McGinley, Jennifer L.
    [J]. PARKINSONISM & RELATED DISORDERS, 2011, 17 (01) : 1 - 9
  • [29] Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study
    Sommerauer, Michael
    Fedorova, Tatyana D.
    Hansen, Allan K.
    Knudsen, Karoline
    Otto, Marit
    Jeppesen, Jesper
    Frederiksen, Yoon
    Blicher, Jakob U.
    Geday, Jacob
    Nahimi, Adjmal
    Damholdt, Malene F.
    Brooks, David J.
    Borghammer, Per
    [J]. BRAIN, 2018, 141 : 496 - 504
  • [30] Longitudinal assessment of autonomic dysfunction in early Parkinson's disease
    Stankovic, Iva
    Petrovic, Igor
    Pekmezovic, Tatjana
    Markovic, Vladana
    Stojkovic, Tanja
    Dragasevic-Miskovic, Nata A.
    Svetel, Marina
    Kostic, Vladimir
    [J]. PARKINSONISM & RELATED DISORDERS, 2019, 66 : 74 - 79